Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:46:25 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Q:DYAI - DYADIC INTERNATIONAL INC - http://www.dyadic.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DYAI - Q3.01.40·1.473.71.46-0.03-2.026.638241.4701  1.52  1.462.40  1.1913:16:58Mar 2815 min RT 2¢

Recent Trades - Last 10 of 24
Time ETExPriceChangeVolume
13:16:58Q1.46-0.035
12:54:22Q1.44-0.0571
12:54:22Q1.46-0.03597
12:54:15Q1.485-0.0052
12:31:39Q1.4703-0.01974
12:23:07Q1.4701-0.0199100
12:10:03Q1.485-0.005100
12:10:03Q1.485-0.0055
12:10:03Q1.49 34
12:08:43Q1.48-0.01100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-28 16:00U:DYAINews ReleaseDyadic Reports 2023 Full Year Results and Recent Company Progress
2024-03-28 08:30U:DYAINews ReleaseDyadic Announces Change in Board and Management Leadership Roles
2024-03-27 08:30U:DYAINews ReleaseDyadic to Attend Industry Events in April
2024-03-26 08:30U:DYAINews ReleaseDyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
2024-03-21 08:30U:DYAINews ReleaseDyadic to Attend Future Food Tech Event March 21 - 22, 2024 in San Francisco, California
2024-03-14 16:30U:DYAINews ReleaseDyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
2024-03-11 09:57U:DYAINews ReleaseCORRECTION - Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
2024-03-11 08:30U:DYAINews ReleaseDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
2024-03-01 08:30U:DYAINews ReleaseDyadic to Attend Industry Events in March
2024-02-28 08:30U:DYAINews ReleaseDyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
2024-02-21 08:30U:DYAINews ReleaseDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and ‚  Emerging Disease Solutions
2024-02-13 08:30U:DYAINews ReleaseDyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
2024-02-06 08:30U:DYAINews ReleaseDyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
2024-02-01 08:30U:DYAINews ReleaseDyadic to Attend BIO CEO & Investor Conference and European Industry Events
2024-01-22 08:02U:DYAINews ReleaseDyadic International, Inc Invites You to Join Us at The Microcap Conference
2024-01-02 08:30U:DYAINews ReleaseDyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
2023-11-30 08:30U:DYAINews ReleaseDyadic Attends Investor Events in December
2023-11-29 08:30U:DYAINews ReleaseDyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
2023-11-20 08:30U:DYAINews ReleaseDyadic ¢ € ™s C1 Platform to be Used to Produce Vaccines for ‚  Humans and Animals in Africa
2023-11-08 16:00U:DYAINews ReleaseDyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress